Considering the potent anti-proliferative effect of this new drug and that DHFR is a validated target for the treatment of toxoplasmosis, we compared the effect of this new drug with trimetrexate and pyrimethamine in a washout assay. This evidence concerns the gene DHFR and toxoplasmosis.